BTK inhibition was also associated with substantial downregulation of oncogenic genes, such as MYC, in prostate cancer cell lines and enhances their chemosensitivity to standard drugs such as docetaxel (Guo et al., 2014). This evidence concerns the gene BTK and Familial prostate cancer.